Eam Investors, LLC Verrica Pharmaceuticals Inc. Transaction History

Eam Investors, LLC

  • $581 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$5.89 - $9.56 $415,751 - $674,802
70,586 New
70,586 $514,000
Q1 2023

Jul 12, 2023
BUY
$2.88 - $8.51 $458,501 - $1.35 Million
159,202 Added 319.28%
209,065 $1.36 Million
Q1 2023

May 12, 2023
BUY
$2.88 - $8.51 $143,605 - $424,334
49,863 New
49,863 $324,000

Others Institutions Holding VRCA

# of Institutions
77
Shares Held
14.2M
Call Options Held
9.9K
Put Options Held
6.5K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email